Work

Comparing progression following systemic and tumor-directed therapy for de novo versus recurrent PSMA PET–defined oligo-M1 prostate cancer: A pooled analysis of SOLAR and SATURN clinical trials.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.64

Authors: Jesus Eduardo Juarez Casillas, John Nikitas, Matthew Rettig, Robert Evan Reiter, Alan Lee, Michael L. Steinberg, Luca Valle, Tahmineh Romero, Jeremie Calais, Johannes Czernin, Sonny Tsai, Nathanael Kane, Abhishek A Solanki, Rachael Sexton, Sai Duriseti, Gholam Reza Berenji, William Aronson, Isla Garraway, Nicholas George Nickols, Amar Upadhyaya Kishan

Institutions: University of California, Los Angeles, VA Greater Los Angeles Healthcare System, Loyola University Chicago, Cancer Research And Biostatistics

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407700534

Cites:

Cited by:

Related to: 10